The EMA's human medicines committee (CHMP) has recommended IL-4 and IL-13 inhibitor Dupixent (dupilumab) to treat adults with moderate to severe PN, a disease which causes hard lumps to form on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback